Series B Completed
Pathios Therapeutics Series B (first close)
A$25m raised
Announced 18 Apr 2024
Investors
Investors
- Bristol Myers Squibb
- Canaan · Existing investor
- Brandon Capital Partners · Existing investor
Investors as the sources name them; a linked name has a FundComb profile. An existing investor is one the source says followed on.
- Company
- Pathios Therapeutics
- Stage
- Series B
- Round
- Series B (first close)
- Amount raised
- A$25m
- Company based in
- United Kingdom
Similar rounds
- Pheon Therapeutics Series B May 2024 · led by TCGX
- Coalesce Series B Apr 2024
- Hysata Series B May 2024 · led by bp Ventures
- Prolific Machines Series B1 Jun 2024 · A$83.7m · led by Ki Tua Fund
- Paper.id Series B Jun 2024
Sources
- 18 Apr 2024 Fundraising Includes New Strategic Investment by Bristol Myers Squibb along with Continued Support from Existing Investors including Canaan and Brandon Capital brandoncapital.vc
- 18 Apr 2024 Pathios Therapeutics Raises $25M in First Close of Series B Financing brandonbiocatalyst.com
- 30 Apr 2024 Pathios Therapeutics Raises $25M in First Close of Series B Financing brandoncapital.vc